Jason Glanz, PhD

Senior Research Investigator
Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado

Disclosure(s): Hillevax: Grant/Research Support

Poster(s):

• (P-41) Effectiveness of recombinant zoster vaccine against postherpetic neuralgia in a real-world setting
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT